Onset and Disease Course of Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitor Therapy at a Single Institution

被引：0
|
作者：
Boutsicaris, Christina [1 ]
Ciliberti, Angelo [2 ]
Lockerman, Elizabeth [1 ]
Siddique, Faizah [3 ]
Ostrowski, Rochella [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Loyola Univ Med Ctr, Oak Pk, IL USA
[3] Loyola Univ Med Ctr, Lombard, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1566
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institution
    Edwards, C. L.
    Comito, F.
    Agraso Busto, S.
    Harland, C.
    Turajlic, S.
    Larkin, J.
    Heelan, K.
    Fearfield, L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (02) : 338 - 341
  • [22] Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis
    Cappelli, Laura C.
    Thomas, Mekha A.
    Bingham, Clifton O., III
    Shah, Ami A.
    Darrah, Erika
    IMMUNOLOGICAL REVIEWS, 2020, 294 (01) : 106 - 123
  • [23] A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
    Thavendiranathan, Paaladinesh
    Sacher, Adrian
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 670 - 672
  • [24] Inflammatory Arthritis Induced by Immune Checkpoint Inhibitor Therapy: A Distinct Clinical Entity and Immunologic Phenotype
    Thanarajasingam, Uma
    Zhu, Xingxing
    Zhou, Xian
    Jaquith, Jane
    Li, Yanfeng
    Zeng, Hu
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Do Patients receiving Immune Checkpoint Inhibitor Therapy have an increased Risk of a more severe COVID-19 Course?
    Ahmed, M.
    Blum, S.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 40 - 40
  • [26] Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Bruera, Sebastian
    Riveiro-Barciela, Mar
    Meara, Alexa
    Suarez-Almazor, Maria E.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2025, 8 (01) : 64 - 70
  • [27] Antibiotic use, clinical outcomes, and systemic immune biomarkers in patients receiving immune checkpoint inhibitor therapy
    von Itzstein, Mitchell S.
    Gonugunta, Amrit S.
    Sheffield, Thomas
    Homsi, Jade
    Dowell, Jonathan E.
    Koh, Andrew Y.
    Raj, Prithvi
    Fattah, Farjana
    Basava, Vijay S.
    Park, Jason Y.
    Popat, Vinita
    Saltarski, Jessica M.
    Gloria-McCutchen, Yvonne
    Hsiehchen, David
    Ostmeyer, Jared
    Khan, Shaheen
    Xie, Yang
    Li, Quan-Zhen
    Wakeland, Edward K.
    Gerber, David E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 168 - 168
  • [28] Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management
    Coleman, Emily
    Ko, Christine
    Dai, Feng
    Tomayko, Mary M.
    Kluger, Harriet
    Leventhal, Jonathan S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 990 - 997
  • [29] Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review
    Tarafdar, Nawar
    Sachdeva, Muskaan
    Savinova, Iryna
    Lytvyn, Yuliya
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (02) : 392 - 395
  • [30] The Clinical Course of Inflammatory Bowel Disease in Patients Receiving Cancer Therapy
    Natha, Cristina M.
    Vemulapalli, Varun
    Haque, Kazi
    Sullivan, Andrew
    Naz, Sidra
    Zhou, Emily
    Haydel, Jasmine
    Quirk, Nina
    Cruz, Carolina Colli
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S818 - S819
12345